This afternoon we watched Elanco Animal Health rise 5.3% to a price of $12.4 per share. The mid-cap Pharmaceutical company is now trading -9.02% below its average target price of $13.63. Analysts have set target prices ranging from $10.0 to $18.0 per share for Elanco Animal Health, and have given the stock an average rating of hold.
Elanco Animal Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.6%. The stock's short ratio is 2.54. Only 0.53% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.
Another number to watch is the company's rate of institutional share ownership, which now stands at 100.7%. In conclusion, we believe there is mixed market sentiment regarding Elanco Animal Health.
Institutions Invested in Elanco Animal Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Dodge & Cox Inc | 17% | 84,203,300 | $1,044,120,887 |
| 2023-09-30 | Primecap Management Company | 10% | 49,168,659 | $609,691,352 |
| 2023-09-30 | Vanguard Group Inc | 10% | 49,001,441 | $607,617,849 |
| 2023-09-30 | Blackrock Inc. | 6% | 27,119,072 | $336,276,482 |
| 2023-09-30 | Price (T.Rowe) Associates Inc | 4% | 19,921,006 | $247,020,466 |
| 2023-09-30 | Shapiro Capital Management Company, Inc. | 3% | 15,795,714 | $195,866,847 |
| 2023-09-30 | Black Creek Investment Management Inc. | 3% | 15,523,457 | $192,490,860 |
| 2023-09-30 | Citadel Advisors Llc | 3% | 13,815,603 | $171,313,471 |
| 2023-09-30 | Dimensional Fund Advisors LP | 2% | 11,278,665 | $139,855,441 |
| 2023-09-30 | State Street Corporation | 2% | 9,642,563 | $119,567,777 |
